HomeSearchBioDrugs

BioDrugs

ADIS INT LTD · Switzerland · Est. 1997

ISSN1173-8804eISSN1179-190X
SJR Q1WOS SCIEScopus / SJR
60
/ 100
Medium Risk
Score Breakdown
WoS SCIE/SSCI+25
Scopus Q1+25
Total60
Journal Impact Factor
This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗
SJR Score
2.29
H-Index
97
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIP
1.621
Total Works
1,691
Total Citations
48,976
2yr Mean Citedness
6.42
Free JIF alternative

Aims & Scope

An essential resource for R&D professionals and clinicians with an interest in biologic therapies. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease .

⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Q1
SJR Rank
Top 25% in field

General Information

Country / RegionSwitzerland
Primary LanguageEnglish
1st Year Published1997
FrequencySix No. A Year 2002-
StatusActive (last: 2026)
Total Publications1,691
Publisher OrgAdis, Springer Healthcare
Visit Journal Website

Submission Info

APC Cost$5,490Above median
Peer Reviewdouble-blind
Review Time
Acceptance Rate
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
📦 Long-term Preservation
CLOCKSS

Think.Check.Submit Compliance

9/12 · 75%
Do you know the journal / publisher?
ADIS INT LTD
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1173-8804 / 1179-190X
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
double-blind
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
$5,490
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
CLOCKSS
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

BiotechnologyQ1
Medicine (miscellaneous)Q1
PharmacologyQ1
Pharmacology (medical)Q1

Subject Classification

Web of Science Categories

ImmunologyOncologyPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)BiotechnologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Biosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies ResearchRheumatoid Arthritis Research and TherapiesCAR-T cell therapy researchImmunotherapy and Immune ResponsesRNA Interference and Gene DeliveryInflammatory Bowel DiseasePharmaceutical Economics and PolicySystemic Lupus Erythematosus ResearchVirus-based gene therapy research
Compare This JournalFind Similar← Back to Search

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref